AI agents are arriving in UK healthcare at a remarkable speed. Trusts across UK healthcare are beginning to adopt automated systems that handle patient queries, produce documentation, route referrals, and support operational and administrative workflows. These tools relieve pressure on overstretched teams but introduce a growing risk that is becoming harder to ignore. Healthcare organisations are beginning to depend on AI outputs that they cannot fully verify. But a confident answer is not the same as hard evidence.
The black box problem: hidden logic, hidden errors
As clinical and operational teams face workforce shortages and sustained workload pressure, reliance on automated systems continues to grow. Many AI agents produce confident, fluent answers while hiding the steps that led to those results. They do not show which data sources were used, what intermediate actions were taken, or how a conclusion was reached. In a sector built on auditability, evidence, and governance, this lack of visibility creates a structural risk.
This concern is already reflected in NHS settings, where clinicians report difficulty trusting systems that cannot provide a clear rationale for their outputs. When an automated recommendation affects patient care or operational throughput, it must be possible to explain how the system arrived at that outcome. Without that, outputs are assumptions, not decisions.
When these systems operate without visibility, subtle issues can pass unnoticed. Repeated outdated, clinical references, incorrect but seemingly-authoritative assumptions, or flawed routing decisions can all pass unnoticed without any clear record of the logic behind it. This is the risk: when AI sounds right but cannot prove why it is right. What is missing is a clear chain of custody for AI-driven actions – an auditable record of what the system accessed, changed, and triggered.
Opacity creates governance gaps
Healthcare organisations already carry significant responsibility for patient safety and legal accountability, but without traceability, AI systems introduce clear governance risks. If actions cannot be traced to their inputs, data sources, and which internal rule was applied, outcomes cannot be reliably validated. This lack of traceability undermines accountability and complicates compliance with governance requirements. It also reflects a broader issue identified in UK research, where the onus of AI-assisted decisions often lies on clinicians, even when system logic is not fully visible or explainable.
Many agentic AI frameworks prioritise fluent outputs over transparent ones. In healthcare settings, this is fundamentally misaligned with the requirements of safe deployment. Healthcare does not need smoother AI; it needs proof of what was done and why. Outputs without evidence are assumptions, not decisions. This gap is increasingly reflected in UK policy direction, where NHS and regulatory guidance emphasise explainability, safety, and accountability as core requirements for AI in clinical environments.
Auditability is the foundation of safe, scalable AI
Addressing this challenge does not require an entirely new generation of AI systems. It requires greater visibility across the AI workflow itself. By instrumenting agents with logging, organisations can capture inputs, actions and system interactions in a single audit trail and identify where outputs diverge from expected behaviour. This includes logging what was accessed, what was changed, and how actions connect across systems through identifiable records.
With this level of traceability, teams can reconstruct how a decision was made, identify failure points, and validate outputs before they impact patient care. Emerging NHS-focused research is already exploring how traceable decision pathways and explainability mechanisms can be embedded into clinical safety frameworks to support auditing and risk management.
This transparency also enables responsible scaling. Clinicians are more likely to trust systems when they can review the reasoning behind outputs, operational teams adopt tools when decision pathways are visible, and leaders invest when systems are demonstrably safe, reliable, and measurable. Regulators, in turn, are more likely to support innovation when evidence is traceable and auditable. Bottom line – transparent systems are easier to trust, adopt and scale.
AI must reveal its logic to be trusted by the NHS
AI will continue to reshape healthcare – the question is whether it does so through transparent systems or hidden logic. In a clinical environment, trust is not built on confident outputs, but on verifiable ones. Healthcare does not need probability without proof; it needs decisions that can be traced, explained, and audited.
The choice facing the NHS is not between innovation and caution, but between systems that can be inspected and those that cannot. Only transparent systems allow clinicians to understand, validate, and stand behind the decisions being made alongside them.
If AI cannot show its working, it cannot safely scale within healthcare. But when its logic is visible, its actions traceable, and its outcomes verifiable, it becomes something the NHS can confidently adopt –not just use, but trust.
Kimber Spradlin
Kimber Spradlin is Chief Marketing Officer at Graylog. With a strong focus on AI-driven optimisation, Kimber leads the adoption of automation and advanced analytics across marketing and sales. Her background in cybersecurity, product management, and regulated environments underpins a disciplined, governance-led approach to sustainable, accountable growth.
